Search

Author/Creator Kosty, Michael

1. Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study†. Issue 5 (8th January 2016)

Authors:
Leon, Larry; Kosty, Michael; Jahanzeb, Mohammad; Spigel, David; Wozniak, Antoinette J.; Brahmer, Julie; Fish, Susan; Flick, E. Dawn; Hazard, Sebastien J.; Lynch, Thomas J.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 25:Issue 5(2016)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas. (18th December 2019)

Authors:
Fortin Ensign, Shannon; Bollin, Kathryn; Millis, Sherri Z.; Hinds, Brian R.; Kosty, Michael; Uchiyama, Christopher
Journal:
Pigment cell & melanoma research
Issue:
Volume 33:Number 3(2020)
Page Start:
458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗